Juan D Cañete Selected Research

Rheumatic Diseases (Rheumatism)

11/2023	Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.
5/2023	Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors.
10/2022	Designing Studies for Epigenetic Biomarker Development in Autoimmune Rheumatic Diseases.
1/2021	Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial.
5/2014	Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis.
12/2013	Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases.
9/2011	[Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].
4/2011	Clinical significance of high levels of soluble tumour necrosis factor-α receptor-2 produced by alternative splicing in rheumatoid arthritis: a longitudinal prospective cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juan D Cañete Research Topics

Disease

60	Rheumatoid Arthritis 03/2024 - 03/2004
36	Psoriatic Arthritis 03/2024 - 05/2004
22	Inflammation (Inflammations) 03/2024 - 07/2008
14	Arthritis (Polyarthritis) 03/2024 - 05/2004
13	Synovitis 03/2024 - 05/2004
8	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 01/2016
8	Rheumatic Diseases (Rheumatism) 11/2023 - 04/2011
7	Infections 01/2020 - 01/2013
6	Palindromic rheumatism 12/2021 - 08/2007
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 05/2008
5	Ankylosing Spondylitis 11/2020 - 08/2012
4	Pain (Aches) 11/2021 - 07/2014
4	Neoplasms (Cancer) 01/2020 - 12/2013
4	Osteoarthritis 03/2016 - 06/2003
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 01/2016
3	Necrosis 01/2021 - 06/2007
3	Fatigue 12/2020 - 07/2016
2	Osteitis 02/2024 - 04/2008
2	Axial Spondyloarthritis 01/2023 - 01/2016
2	Multiple Sclerosis 01/2023 - 01/2020
2	Asthma (Bronchial Asthma) 01/2023 - 01/2021
2	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2020
2	Uveitis 01/2020 - 03/2018
2	Injection Site Reaction 01/2020 - 06/2015
2	Ulcerative Colitis 06/2017 - 01/2016
2	Crohn Disease (Crohn's Disease) 06/2017 - 01/2016
2	Hyperplasia 09/2011 - 08/2006
1	Experimental Arthritis 02/2024
1	Arthralgia (Joint Pain) 02/2024
1	Tenosynovitis 02/2024
1	Spondylarthritis (Spinal Arthritis) 01/2023
1	Hidradenitis Suppurativa 01/2023
1	Mycoses (Diseases, Fungus) 01/2023
1	Fever (Fevers) 12/2021
1	Abdominal Pain (Pain, Abdominal) 12/2021
1	Pericarditis 12/2021
1	Obesity 06/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2020

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2014
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 03/2004
11	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2006
11	CytokinesIBA 11/2019 - 07/2008
9	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 08/2012
8	Antirheumatic Agents (DMARD)IBA 03/2024 - 01/2017
8	Leukocyte L1 Antigen Complex (Calgranulin)IBA 03/2024 - 12/2015
8	Etanercept (Enbrel)FDA Link 11/2023 - 03/2004
8	AutoantibodiesIBA 05/2022 - 06/2007
8	Infliximab (Remicade)FDA Link 01/2016 - 03/2004
7	Interleukin-17 (Interleukin 17)IBA 03/2024 - 07/2015
6	AntibodiesIBA 01/2022 - 01/2009
6	Peptides (Polypeptides)IBA 01/2020 - 01/2009
5	InterleukinsIBA 03/2024 - 03/2012
5	C-Reactive ProteinIBA 01/2022 - 01/2016
5	Adalimumab (Humira)FDA Link 01/2016 - 08/2012
4	Methotrexate (Mexate)FDA LinkGeneric 03/2024 - 05/2004
4	Immunomodulating AgentsIBA 01/2023 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 09/2015
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 12/2015
3	Janus Kinase InhibitorsIBA 03/2024 - 01/2022
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2021
3	Anti-Citrullinated Protein AntibodiesIBA 02/2024 - 08/2007
3	acetyl 4-aminosalicylic acidIBA 02/2024 - 05/2008
3	tocilizumab (atlizumab)FDA Link 11/2023 - 12/2015
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2022 - 09/2015
3	Rheumatoid FactorIBA 12/2021 - 09/2009
3	ametantrone (HAQ)IBA 11/2021 - 12/2020
2	Interleukin-23 Subunit p19IBA 03/2024 - 07/2015
2	Abatacept (Orencia)FDA Link 02/2024 - 05/2010
2	Rituximab (Mabthera)FDA Link 11/2023 - 01/2021
2	NF-kappa B (NF-kB)IBA 01/2023 - 01/2009
2	Interleukin-23 (Interleukin 23)IBA 01/2023 - 07/2015
2	Monoclonal AntibodiesIBA 01/2022 - 06/2015
2	EpitopesIBA 01/2017 - 09/2009
2	LigandsIBA 07/2015 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 05/2013
2	ChemokinesIBA 07/2008 - 06/2007
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 03/2024
1	LipidsIBA 03/2024
1	OxylipinsIBA 03/2024
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 03/2024
1	Metformin (Glucophage)FDA LinkGeneric 11/2023
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2023
1	Immune Checkpoint InhibitorsIBA 08/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2022
1	Colchicine FDA LinkGeneric 12/2021
1	Genetic Markers (Genetic Marker)IBA 10/2021
1	OvalbuminIBA 01/2021
1	mepolizumabIBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Interleukin-6 InhibitorsIBA 10/2020
1	Prostaglandins AIBA 06/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	CannabinoidsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Anti-Idiotypic AntibodiesIBA 01/2020

Therapy/Procedure

26	Therapeutics 03/2024 - 05/2004
12	Biological Therapy 11/2023 - 09/2011
1	Immunotherapy 08/2022